Modeyso

MARKETERJAZZ PHARMACEUTICALS Modeyso is the first and only FDA-approved treatment for adult and pediatric patients aged 1 year and older with H3 K27M-mutant diffuse midline glioma (DMG) following progression after prior therapy. Dordaviprone is an orally administered, blood-brain barrier-penetrant small molecule imipridone that selectively targets dopamine receptor D2 (DRD2) and the mitochondrial protease ClpP, activating … Continued

JNJ-1900 (NBTXR3)

GLOBAL PARTNERJOHNSON & JOHNSON JNJ-1900 (NBTXR3) is a novel, potentially first-in-class oncology product composed of functionalized hafnium oxide nanoparticles that is administered via one-time intratumoral injection and activated by radiotherapy. The product candidate’s mechanism of action (MoA) is designed to induce significant tumor cell death in the injected tumor when activated by radiotherapy, subsequently triggering … Continued

BEYONTTRA

MARKETERBAYER AG Beyonttra (acoramidis) is a twice daily, oral, small-molecule, transthyretin (TTR) stabilizer indicated for the treatment of wild-type or variant transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM). ATTR-CM is a progressive disease caused by destabilization of TTR and subsequent accumulation of misfolded TTR protein in the myocardium. This leads to heart failure and, … Continued

IQIRVO

MARKETERIPSEN Iqirvo® (elafibranor) is a first-in-class, once-daily oral peroxisome proliferator-activated receptor (PPAR) alpha and delta agonist indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA. PBC is a rare, chronic cholestatic liver … Continued

TLX250-CDx

MARKETERTELIX PHARMACEUTICALS, LTD. TLX250-CDx (89Zr-DFO-girentuximab) is a microdose radiopharmaceutical Positron Emission Tomography (PET) imaging agent in development by Telix Pharmaceuticals for the diagnosis of clear cell renal cell carcinoma (ccRCC), the most aggressive and common form of kidney cancer. TLX250-CDx is a radiolabeled form of the antibody girentuximab which binds to the tumor-specific antigen carbonic … Continued

KORSUVA

MARKETERCSL Vifor/Maruishi Pharmaceutical Co. Korsuva (difelikefalin, known as Korsuva in the US and Japan and Kapruvia in other regions) is an intravenously administered kappa-opioid receptor agonist indicated for pruritus in chronic kidney disease (CKDaP) patients undergoing hemodialysis. This product was approved in US/EU in 2022 and in Japan in 2023. Background HCRx purchased the right … Continued

Rezurock

MARKETERSANOFI Rezurock (belumosudil mesylate) is an orally administered selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), indicated for chronic Graft vs Host Disease (cGVHD) after failure of at least two prior lines of systemic therapy. FDA approved Rezurock in 2021. Background HCRx purchased a right to receive royalties and milestones due from Sanofi with respect … Continued

Hemgenix

MARKETERCSL LIMITED HEMGENIX® is a gene therapy that reduces the rate of abnormal bleeding in eligible people with hemophilia B by enabling the body to continuously produce factor IX, the deficient protein in hemophilia B. It uses AAV5, a non-infectious viral vector, called an adeno-associated virus (AAV). The AAV5 vector carries the Padua gene variant … Continued

XIPERE ET AL

MARKETERS & DEVELOPERSBAUSCH + LOMB CORPORATION, ARCTIC VISION (HONG KONG) LIMITED, REGENXBIO INC., AURA BIOSCIENCES, INC. The SCS Microinjector is a proprietary injection device for administration of drugs into the suprachoroidal space of the eye. Injecting drugs into the suprachoroidal space allows therapy to reach the areas of the eye where sight-threatening disease often occurs … Continued

Lumify

MarketerBausch + Lomb Lumify® eye drops (brimonidine tartrate ophthalmic solution, 0.025%) are the first and only OTC eye drop developed with low dose brimonidine tartrate for the relief of eye redness due to minor eye irritations.  The product can be used as both an ocular health and cosmetic agent that reduces redness to help eyes … Continued

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.